title: Clarification of FDA and The Joint Commission reporting requirements for US tissue recipient adverse reactions.
authors.forename: Tina
authors.initials: T
authors.lastname: Khoie
authors.forename: Craig E
authors.initials: CE
authors.lastname: Zinderman
authors.forename: Ruth
authors.initials: R
authors.lastname: Solomon
authors.forename: Robert P
authors.initials: RP
authors.lastname: Wise
authors.forename: Karen C
authors.initials: KC
authors.lastname: Lee
authors.forename: Klaus
authors.initials: K
authors.lastname: Nether
mesh_terms: D001424:Bacterial Infections / Q000635:transmission*; D003140:Communicable Disease Control / Q000592:standards; D006801:Humans; D016378:Tissue Transplantation / Q000009:adverse effects* / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards*